Biotechnology News

October 31, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm Corporation (NASDAQ:FLDM) will report its third quarter 2012 financial results on November 7, 2012, after close of market.

October 31, 2012

MILAN--(BUSINESS WIRE)--Sorin Group Announces Third Quarter Results

October 31, 2012

DES MOINES, Iowa--(BUSINESS WIRE)--Americans for Choice and Competition in Agriculture reacts to progress made by agriculture industry stakeholders in developing a framework for the seed marketplace.

October 31, 2012

WESTBOROUGH, Mass.--(BUSINESS WIRE)--Ameridose today announced it will commence a voluntary recall of any unexpired products remaining in circulation. This action is voluntary, and represents an expansion of our cooperation with the U.S. Food and...

October 31, 2012

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: The Extraordinary General Meeting of Vitrolife (STO:VITR) held on September 24 adopted a resolution regarding a private placement of EUR 1.352.315 in order to partly finance the acquisition of...

October 31, 2012

UPPSALA, Sweden--(BUSINESS WIRE)--Regulatory News: The number of shares and votes in Orexo (STO:ORX) has changed as a result of the exercise of warrants. Today, the last trading day of the month, there are in total 29,922,909 shares and votes in...

October 31, 2012

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Due to the effects of Hurricane Sandy on the Eastern seaboard, CardioNet, Inc. (NASDAQ:BEAT) is postponing the release of its Third Quarter 2012 financial results to Monday, November 5 at 4 PM Eastern Time. The...

October 31, 2012

WASHINGTON--(BUSINESS WIRE)--For the first time, researchers can visualize in 3-D the stresses induced by flowing blood in an embryonic heart. The technique promises to provide new insight into how and why heart defects develop.

October 31, 2012

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Medical Imaging, Inc. (Lantheus or the Company) and two world leaders in producing medical isotopes have agreed to work together to help ensure supplies of potentially life-saving nuclear medicine...

October 31, 2012

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals today announced that it filed the resubmission of its Lymphoseek® NDA to the FDA in response to the CRL received in September 2012.

October 31, 2012

PRINCETON, N.J.--(BUSINESS WIRE)--Advaxis announces financing

October 31, 2012

PRINCETON, N.J.--(BUSINESS WIRE)--Advaxis updates preliminary data from India study

October 31, 2012

BOSTON & GENEVA--(BUSINESS WIRE)--PHT Corporation, world's leading provider of innovative technology systems used to collect patient-driven eData for clinical research, appoints Dr. Susan Dallabrida Senior Scientific Advisor

October 31, 2012

EXTON, Pa.--(BUSINESS WIRE)--BioTrends Research Group, one of the world’s leading research and advisory firms for specialized biopharmaceutical issues, finds that, nearly half of surveyed gastroenterologists, unaided, note that they are using...

October 31, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced the initiation of the Phase 3 CB-5945 opioid-induced constipation (OIC) Ascent program with the enrollment of the first patient in the long-term safety...

October 31, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Asahi Kasei Pharma America initiated its Phase 3 clinical trial of ART-123, a novel, recombinant, human soluble thrombomodulin alpha, for the treatment of severe sepsis with coagulopathy.

October 31, 2012

TEL AVIV, Israel--(BUSINESS WIRE)--Compugen Ltd. (NASDAQ: CGEN), announced today the discovery and initial validation of two new drug target candidates for monoclonal antibody (mAb) cancer therapy. These new candidates have been shown to be...

October 31, 2012

WOBURN, Mass.--(BUSINESS WIRE)--Courtagen's new genetic test, epiSEEK™, provides the complete sequence of 327 genes that have been reported in association with epilepsy phenotypes and nonspecific seizure disorders.

October 31, 2012

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Anja Moellman, Senior Project Director for Theorem Clinical Research will present on the opportunities and challenges of clinical research in China at the Partnerships in Clinical Trials conference.

October 31, 2012

SAN CARLOS, Calif.--(BUSINESS WIRE)--Natera today announced that data from a clinical study published in Prenatal Diagnosis demonstrate the ability of the company’s non-invasive prenatal screening test to detect chromosomal abnormalities from...

October 31, 2012

WESTON, Mass. & STOCKHOLM, Sweden--(BUSINESS WIRE)--Biogen Idec (NASDAQ: BIIB) and Swedish Orphan Biovitrum (Sobi) (STO: SOBI) today announced positive results from A-LONG, a clinical study that evaluated a new long-lasting clotting factor...

October 31, 2012

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that a Phase 2 clinical trial evaluating tenofovir alafenamide fumarate (TAF; formerly referred to as GS-7340), an investigational novel prodrug of...

October 31, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aileron Therapeutics, Inc., a biopharmaceutical company developing and advancing a revolutionary class of drugs called Stapled Peptides, today announced the company’s participation in several upcoming scientific...

October 31, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Verastem will present preclinical data on its programs in FAK and PI3K/mTOR at the EORTC-NCI-AACR meeting, November 6-9, 2012 in Dublin, Ireland.

October 31, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be participating in the 2012 Brean Capital Life Sciences Summit on November 7, 2012 in New York City. In addition, Infinity will be presenting at the Lazard...

October 31, 2012

PARIS--(BUSINESS WIRE)--Mobile payment, identification or urban mobility smart technologies are taking an increasing part of everyday life. Exhibitors from the smart technology industry will make the most of CARTES 2012 Exhibition and Conference...

October 31, 2012

JERUSALEM--(BUSINESS WIRE)--Yissum Research and Development Company of the Hebrew University of Jerusalem, the technology transfer company of the Hebrew University, announced today the inception of its subsidiary, Integra Holdings, a holding...

October 31, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will host a live webcast of its quarterly conference call at 8:30 a.m. (ET) on Wednesday, November 7, 2012. Harvey J. Berger, M.D., chairman and...

October 31, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Emergent BioSolutions Inc. (NYSE: EBS) announced today the initiation of a Phase 1b study (Protocol 16009) of TRU-016 in combination with rituximab for patients with previously untreated chronic lymphocytic...

October 31, 2012

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (NASDAQ:SGEN) today announced that its collaborator, Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, announced that the European...

October 31, 2012

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum to host a teleconference and webcast with management to discuss the third quarter 2012 financial results, provide an update on the Company's business, and discuss expectations for the future

October 31, 2012

NEW YORK--(BUSINESS WIRE)--Medidata Solutions today announced its financial results for the third quarter of 2012, and provided detailed financial guidance for the fourth quarter and full year 2012.

October 31, 2012

WATERTOWN, Mass.--(BUSINESS WIRE)--EnVivo Pharmaceuticals Presents Additional EVP-6124 Phase 2b Clinical Trial Results at the Clinical Trials on Alzheimer’s Disease (CTAD) Meeting

October 31, 2012

MANCHESTER, England--(BUSINESS WIRE)--Gentronix Limited, the genotoxicity innovation and service company, has received French research tax credit approval for years 2012 through 2014.

October 31, 2012

NEW YORK & UXBRIDGE, United Kingdom--(BUSINESS WIRE)--Medidata Solutions was selected by Sanofi as the clinical technology standard for clinical data collection, management and reporting and performance-enhancing analytics across entire R...

October 31, 2012

ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced its financial results for the third quarter ended September 30, 2012. “We were pleased with AMPYRA’s performance in the third quarter, with net sales of $69....

October 31, 2012

SAN DIEGO--(BUSINESS WIRE)--DaVita will present 13 abstracts at the American Society of Nephrology (ASN) Kidney Week in San Diego, November 1-4. Attendees can find DaVita representatives in booth #1903.

October 31, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and other neurotrauma conditions, today announced the Company’s sponsorship...

October 31, 2012

INGELHEIM, Germany--(BUSINESS WIRE)--For Non-US, Non-UK & Non-Canadian Media Only Widely anticipated results from RELY-ABLE®, the first long-term follow-up study of a novel oral anticoagulant treatment for stroke prevention in AF, will be...

October 31, 2012

CAMBRIDGE, Mass. & OSAKA, Japan--(BUSINESS WIRE)--Millennium and Takeda announce European Commission marketing authorization for ADCETRIS in relapsed or refractroy HL and relapsed and refractory sALCL.

October 31, 2012

OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda and Millennium today announced that the European Commission (EC) has granted conditional marketing authorisation for ADCETRIS in relapsed/refractory HL and relapsed or refractory sALCL...

October 31, 2012

VÄSTRA FRÖLUNDA, Sweden--(BUSINESS WIRE)--Regulatory News: FIRST NINE MONTHS • Net revenue increased by nine percentage points and amounted to SEK 15.6 million (14.3). • The net loss after tax totaled SEK 10.2 million (11.9). This respresented an...

October 31, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: As previously announced, the number of shares and votes in Precise Biometrics (STO:PREC) has increased following a rights issue. With reference to chapter 4 section 9 (1991:980) of the Swedish...

October 31, 2012

SOLNA, Sweden--(BUSINESS WIRE)--Regulatory News: With reference to Chapter 4 Section 9 in ”lagen (1991:980) om handel med finansiella instrument” it’s hereby announced that through the subscription by exercise of options in Aerocrine the number...

October 31, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Inspiration Biopharmaceuticals, Inc. (Inspiration), a biopharmaceutical company dedicated solely to the development of products for hemophilia, today announced that it has filed for protection under Chapter 11...

October 31, 2012

PARIS--(BUSINESS WIRE)--Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced that Inspiration Biopharmaceuticals Inc. (Inspiration) has commenced a voluntary reorganization case pursuant to Chapter 11’s provisions of the United...

October 30, 2012

BEDFORD, Mass.--(BUSINESS WIRE)--Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair, based on hyaluronic acid (“HA”) technology, today reported financial results for the quarter ended September...

October 30, 2012

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories issues third-quarter 2012 financial results